Market Indices
Sector Heatmap
MNPR — Monopar Therapeutics Inc. Common Stock
NasdaqMonopar Therapeutics Inc. Common Stock
- O
- 78.04
- H
- 82.66
- L
- 75.33
- V
- 301.96K
MNPR — Latest News & Headlines
16 StoriesAfter a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. - Stock Titan
After a $0.005-per-share option exercise, Monopar Therapeutics (MNPR) director sells 8,400 shares. Stock Titan
Responsive Playbooks and the MNPR Inflection - Stock Traders Daily
Responsive Playbooks and the MNPR Inflection Stock Traders Daily
Stock-option shares are proposed for sale by Chandler Robinson at Monopar Therapeutics (NASDAQ: MNPR). - Stock Titan
Stock-option shares are proposed for sale by Chandler Robinson at Monopar Therapeutics (NASDAQ: MNPR). Stock Titan
Monopar Therapeutics CEO Robinson sells $2.5m in stock - Investing.com
Monopar Therapeutics CEO Robinson sells $2.5m in stock Investing.com
Monopar Therapeutics stock trades on a clinical pipeline catalyst - AD HOC NEWS
Monopar Therapeutics stock trades on a clinical pipeline catalyst AD HOC NEWS
16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. - Stock Titan
16,800 shares are proposed for sale by Monopar Therapeutics (MNPR) director Christopher Starr. Stock Titan
MNPR Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slide - Long-Term Guidance - https://www.siam.in/
MNPR Q2 2026 Earnings: Narrower-Than-Expected Loss, Yet Shares Slide - Long-Term Guidance https://www.siam.in/
Monopar Therapeutics director Starr sells $659,386 in stock By Investing.com - Investing.com UK
Monopar Therapeutics director Starr sells $659,386 in stock By Investing.com Investing.com UK
Monopar Therapeutics stock faces insider selling after Q2 loss - AD HOC NEWS
Monopar Therapeutics stock faces insider selling after Q2 loss AD HOC NEWS
For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. - Stock Titan
For withholding tax, Monopar Therapeutics (MNPR) withholds 1,944 shares from its COO. Stock Titan
4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). - Stock Titan
4,344 CEO shares were withheld for taxes by Monopar Therapeutics (MNPR). Stock Titan
Monopar Therapeutics stock falls 7.5 percent on September 23 - AD HOC NEWS
Monopar Therapeutics stock falls 7.5 percent on September 23 AD HOC NEWS
180 shares cover CFO taxes as Monopar Therapeutics (MNPR) settles a 614-share stock grant. - Stock Titan
180 shares cover CFO taxes as Monopar Therapeutics (MNPR) settles a 614-share stock grant. Stock Titan
Four share sales at $87.15 to $89.79: Monopar Therapeutics (MNPR) CEO also exercised options. - Stock Titan
Four share sales at $87.15 to $89.79: Monopar Therapeutics (MNPR) CEO also exercised options. Stock Titan
MNPR rises as buyers remain active during intraday volatility - Traders Union
MNPR rises as buyers remain active during intraday volatility Traders Union
Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support - Traders Union
Form 4 insider transaction filed pressures Monopar Therapeutics stock below $74.23 support Traders Union